These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 4697470)
1. Levodopa and related drugs. Med Lett Drugs Ther; 1973 Mar; 15(5):21-3. PubMed ID: 4697470 [No Abstract] [Full Text] [Related]
2. L-dopa. II. Br Med J; 1970 Nov; 4(5734):541-2. PubMed ID: 4099003 [No Abstract] [Full Text] [Related]
3. Recent advances in the treatment of Parkinsonism with drugs. Rinne UK Acta Neurol Scand Suppl; 1972; 51():59-103. PubMed ID: 4576076 [No Abstract] [Full Text] [Related]
4. A second report on Levodopa. Med Lett Drugs Ther; 1969 Sep; 11(18):73-5. PubMed ID: 5394281 [No Abstract] [Full Text] [Related]
5. Therapeutic uses and side effects of L-dopa. Boshes B Adv Intern Med; 1972; 18():219-49. PubMed ID: 4576081 [No Abstract] [Full Text] [Related]
6. Levodopa and amantadine in the treatment of Parkinsonism. Critchley E Practitioner; 1972 Apr; 208(246):499-504. PubMed ID: 5031037 [No Abstract] [Full Text] [Related]
7. [Conservative therapy in the Parkinson syndrome]. Birkmayer W Wien Med Wochenschr; 1971 Nov; 121(46):827-9. PubMed ID: 5138823 [No Abstract] [Full Text] [Related]
8. L-Dopa treatment in Parkinson's Disease. Rinne UK; Sonninen V; Siirtola T Eur Neurol; 1970; 4(6):348-69. PubMed ID: 4932969 [No Abstract] [Full Text] [Related]
9. [Medical treatment of Parkinson's disease]. Castaigne P; Rondot P; Ribadeau-Dumas JL Ann Med Interne (Paris); 1972 Apr; 123(4):357-64. PubMed ID: 5077040 [No Abstract] [Full Text] [Related]
11. L-dopa therapy in Parkinson's disease. Lipman IJ Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138 [No Abstract] [Full Text] [Related]
12. [Indications and results of monoamine treatment in parkinsonian syndromes]. Boudin G; Pépin B; Guillard A; Fabiani JM; Haguenau M Rev Neurol (Paris); 1972 Jul; 127(1):79-97. PubMed ID: 4520464 [No Abstract] [Full Text] [Related]
13. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride. Reveno WS; Bauer RB; Rosenbaum H Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462 [No Abstract] [Full Text] [Related]
14. Parkinson's disease treated with L-dopa. Three-year follow-up report. Mones RJ N Y State J Med; 1972 Nov; 72(22):2749-50. PubMed ID: 4510706 [No Abstract] [Full Text] [Related]
15. [The current treatment of Parkinson's disease]. Gonce M; Barbeau A Rev Med Liege; 1976 Oct; 31(19):563-73. PubMed ID: 790511 [No Abstract] [Full Text] [Related]
16. Augmenting the action of levodopa. Rao SK; Vakil SD; Calne DB; Hilson A Postgrad Med J; 1972 Nov; 48(565):653-6. PubMed ID: 4568331 [TBL] [Abstract][Full Text] [Related]
17. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease. Andrews CJ; Somerville B Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384 [No Abstract] [Full Text] [Related]
18. Levodopa combined with peripheral decarboxylase inhibition in Parkinson's disease. Barbeau A; Mars H; Botez MI; Joubert M Can Med Assoc J; 1972 Jun; 106(11):1169-74. PubMed ID: 5034697 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of and possible differences in tolerance to L-dopa tablets with different rates of release of the active substance. Völler GW; Muschard F Acta Neurol Scand; 1974; 50(3):391-3. PubMed ID: 4525037 [No Abstract] [Full Text] [Related] [Next] [New Search]